Diurnal Group PLC | Ownership
Companies that own Diurnal Group PLC
Invesco Asset Management Ltd.
7,165,589
11.68%
637,812
0.02%
04/05/2018
Oceanwood Capital Management LLP
4,246,833
6.92%
774,611
2.29%
10/13/2017
Rowan Dartington & Co. Ltd. (Broker)
1,245,000
2.02%
0
0.32%
07/02/2018
Polar Capital LLP
1,052,632
1.72%
0
0.01%
07/31/2018
Rathbone Investment Management Ltd.
354,000
0.57%
285,000
0%
07/02/2018
Morgan Stanley Securities Ltd. (Market-Maker)
100,000
0.16%
100,000
0.02%
07/02/2018
Hargreaves Lansdown Stockbrokers Ltd.
99,000
0.16%
12,000
0%
07/02/2018
Hargreaves Lansdown Asset Management Ltd.
39,000
0.06%
-2,000
0%
07/02/2018
Walker Crips Stockbrokers Ltd.
38,000
0.06%
38,000
0%
07/02/2018
Jarvis Investment Management Ltd.
27,000
0.04%
9,000
0%
07/02/2018
| Address |
Cardiff Medicentre
Cardiff South Glamorgan CF14 4UJ
United Kingdom
|
|
Employees
|
- |
| Website |
http://diurnal.co.uk |
| Updated |
07/08/2019 |
| Diurnal Group Plc is a specialty pharmaceutical company which addresses the unmet clinical and patient needs for hormone replacement treatments by creating products for life-long treatment for the chronic conditions, which include adrenal insufficiency, rheumatoid arthritis, hypogonadism and hypothryroidism. Its hormone therapeutics is used for proprietary formulations and novel physiological treatment regimes of approved drugs. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. |
